Exhibiting at VIV Asia 2025

The company’s research-driven approach ensures the development of innovative and highly effective veterinary pharmaceuticals, aligning with global One Health initiatives.

Unique Selling Proposition (USP)

1. Scientifically Developed Veterinary Pharmaceuticals – Ensuring animal health and productivity.
2. Strong Research & Development Capabilities – Collaboration with universities and research institutions.
3. Comprehensive Product Portfolio – Covering antibiotics, vaccines, and feed additives.
4. Regulatory Compliance & Quality Assurance – Meeting international standards.
5. Global Expansion Strategy – Exporting veterinary medicines to multiple international markets.

Financial Performance

The global veterinary pharmaceuticals market is projected to reach $50 billion by 2028, with an expected CAGR of 6.8%. As a major player in Asia’s veterinary medicine sector, Cheil Bio has consistently expanded its market share through strategic partnerships and continuous investment in R&D.

International Presence & Shipment Data

Cheil Bio Co., Ltd. has a strong presence in Asia, the Middle East, Africa, and Latin America, exporting its veterinary pharmaceuticals to over 25 countries. Major export destinations include:

• Asia – South Korea, China, Japan, Vietnam, Thailand, Indonesia.
• Middle East & Africa – United Arab Emirates, Saudi Arabia, Egypt, South Africa.
• Europe – Germany, Poland, Italy, Spain.
• Latin America – Brazil, Mexico, Argentina, Chile.

The company has achieved a steady increase in global shipments, with millions of vaccine doses and antibiotic treatments supplied annually.

Certifications & Compliance

Cheil Bio adheres to stringent quality standards and holds multiple international certifications, ensuring the safety and efficacy of its products:

• GMP (Good Manufacturing Practice) Certification – Ensuring high-quality pharmaceutical production.
• ISO 9001: Quality Management System – Certified excellence in manufacturing and quality control.
• KFDA (Korea Food & Drug Administration) Approval – Regulatory compliance for veterinary medicines.
• HACCP Certification – Safety measures in feed additive production.
• EU Regulatory Compliance – Meeting European market requirements.

These certifications highlight Cheil Bio’s commitment to global health and safety standards.

Client Testimonials

“Cheil Bio’s antibiotic solutions have significantly improved our livestock health and reduced mortality rates.” – Dairy Farm Owner, South Korea

“Their probiotic feed additives have enhanced gut health and boosted poultry productivity.” – Poultry Producer, Thailand

Major Achievements

• Over 30 Years of Leadership in veterinary pharmaceuticals and animal health.
• Successful Expansion into 25+ International Markets, solidifying its global presence.
• Development of Advanced Veterinary Vaccines, reducing disease outbreaks in livestock.
• Continuous R&D Investments, driving innovation in animal healthcare solutions.
• Recognition as a Top Veterinary Pharmaceutical Supplier in Asia.

Cheil Bio Co., Ltd. continues to pioneer veterinary medicine advancements, contributing to global animal health, food safety, and sustainable livestock production.